Stockscreener 앱 받기
1.10
8.91%
0.09
시간 외 거래:
1.10
Cel-Sci Corp. 주식(CVM)의 최신 뉴스
[424B5] CEL SCI CORP Prospectus Supplement (Debt Securities) - Stock Titan
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month - Mena FN
CEL-SCI Corporation (CVM) Prices Public Offering, Shares Drop in Premarket - GuruFocus
CEL-SCI stock sale prices $2.5M to fund Multikine work - Stock Titan
CEL-SCI Corporation Announces Pricing of Offering - Yahoo Finance
CVM: CEL-SCI Partners with Saudi Amarox for Strategic Agreement - GuruFocus
CEL-SCI to formalize Saudi Arabia distribution agreement - Investing.com
Saudi cancer immunotherapy push brings CEL-SCI Multikine deal - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cel-Sci Stock Slides 5.43% as Key Support Test LoomsBullish Pattern Stocks - newsline.com
CVM Technical Analysis | Trend, Signals & Chart Patterns | CEL-SCI CORP (NYSEARCA:CVM) - ChartMill
Cel-Sci (CVM) Holds Near Support as Biotech Stock Posts Modest GainChaikin Flow - newsline.com
CVM - Finviz
[RW] CEL SCI CORP SEC Filing - Stock Titan
CVM: CEL-SCI Advances Multikine Toward Regulatory Approval - GuruFocus
Cel Sci CEO Geert Kersten’s trust buys $360,000 in common stock By Investing.com - Investing.com South Africa
Cel Sci CEO Geert Kersten’s trust buys $360,000 in common stock - Investing.com Australia
Cel Sci Insider Bought Shares Worth $360,000, According to a Recent SEC Filing - marketscreener.com
CEL-SCI (NYSE: CVM) trust buys 300K restricted shares at $1.20 - Stock Titan
CEL-SCI adds Saudi partner, U.S. trial for head and neck cancer drug - Stock Titan
Cel-Sci: Fiscal Q2 Earnings Snapshot - cbs19news.com
CEL SCI CORP 1H 2026: Net loss $(10.94M), Diluted EPS $(1.35) — 10-Q Summary - TradingView
CEL-SCI Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 - marketscreener.com
CEL-SCI (NYSE: CVM) reports $10.9M loss and just $1.9M in cash - Stock Titan
CEL-SCI Partners with Amarox for Multikine Cancer Immunotherapy Commercialization in Saudi Arabia and GCC Region 12 - minichart.com.sg
CVM SEC FilingsCEL-SCI Corp 10-K, 10-Q, 8-K Forms - Stock Titan
CEL-SCI (NYSE: CVM) partners with Amarox on Multikine in Saudi Arabia - Stock Titan
CEO Geert Kersten Increases Stake in CEL-SCI Corp with Recent Sh - GuruFocus
Cel-Sci Corporation Common Stock (NY: CVM - FinancialContent
CEO Geert Kersten Increases Stake in CEL-SCI Corp with Recent Share Purchase - GuruFocus
Cel Sci CEO Geert Kersten acquires $119,000 in common stock - Investing.com India
Cel Sci CEO Geert Kersten acquires $119,000 in common stock By Investing.com - Investing.com South Africa
CEL SCI (CVM) CEO Geert Kersten purchases 100,000 restricted shares - Stock Titan
CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity - TradingView
CEL-SCI (NYSE: CVM) prices $7.2M best-efforts stock offering - Stock Titan
CEL-SCI closes $7.2M public offering at $1.20 per share - Investing.com
Cancer immunotherapy firm CEL-SCI raises $7.2M for Multikine - Stock Titan
CEL‑SCI (NYSE American: CVM) to sell 6.0M shares; raises ~$6.5M net - Stock Titan
Cel-Sci Corp files for offering of 6 million shares of common stockSEC filing - marketscreener.com
Cel-Sci Corp Files For Offering Of 6 Million Shares Of Common Stock- SEC Filing - TradingView
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] CEL SCI CORP SEC Filing - Stock Titan
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did CEL-SCI Stock Plunge After Its Latest Offering - Kavout
CVM: ThinkEquity Completes Sole Management of Offering - GuruFocus
CEL-SCI prices $7.2M public offering at $1.20 per share By Investing.com - Investing.com South Africa
CEL-SCI prices $7.2M public offering at $1.20 per share - Investing.com
Cancer immunotherapy firm CEL-SCI seeks $7.2M to develop Multikine - Stock Titan
CEL-SCI Corporation Announces Pricing of Public Offering - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
2.60%
0.94%
자본화:
|
볼륨(24시간):